Cargando…

Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review

BACKGROUND: Biomarkers that can predict the prognosis of colorectal cancer (CRC) patients and that can stratify high-risk early stage patients from low-risk early stage patients are urgently needed for better management of CRC. During the last decades, a large variety of prognostic DNA methylation m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Draht, Muriel X. G., Goudkade, Danny, Koch, Alexander, Grabsch, Heike I., Weijenberg, Matty P., van Engeland, Manon, Melotte, Veerle, Smits, Kim M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851322/ https://www.ncbi.nlm.nih.gov/pubmed/29564023 http://dx.doi.org/10.1186/s13148-018-0461-8

Ejemplares similares

Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome
por: Draht, Muriel X. G., et al.
Publicado: (2016)

Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC
por: Rademakers, Glenn, et al.
Publicado: (2021)

Investigation of sirtuin 1 polymorphisms in relation to the risk of colorectal cancer by molecular subtype
por: Hrzic, Rok, et al.
Publicado: (2020)

Expression of proteins associated with the Warburg‐effect and survival in colorectal cancer
por: Offermans, Kelly, et al.
Publicado: (2021)

Technical considerations in PCR-based assay design for diagnostic DNA methylation cancer biomarkers
por: Massen, Maartje, et al.
Publicado: (2022)

Promoter Methylation Precedes Chromosomal Alterations in Colorectal Cancer Development
por: Derks, Sarah, et al.
Publicado: (2006)

Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review
por: de Ruijter, Tim C., et al.
Publicado: (2020)

Lifestyle, Diet, and Colorectal Cancer Risk According to (Epi)genetic Instability: Current Evidence and Future Directions of Molecular Pathological Epidemiology
por: Hughes, Laura A. E., et al.
Publicado: (2017)

Body Size, Physical Activity and Risk of Colorectal Cancer with or without the CpG Island Methylator Phenotype (CIMP)
por: Hughes, Laura A. E., et al.
Publicado: (2011)

Lessons From a Systematic Literature Search on Diagnostic DNA Methylation Biomarkers for Colorectal Cancer: How to Increase Research Value and Decrease Research Waste?
por: Feng, Zheng, et al.
Publicado: (2022)

Lamin A/C Is a Risk Biomarker in Colorectal Cancer
por: Willis, Naomi D., et al.
Publicado: (2008)

Association between adjuvant therapy and survival in colorectal cancer patients according to metabolic Warburg-subtypes
por: Offermans, Kelly, et al.
Publicado: (2023)

Dietary methyl donors, methyl metabolizing enzymes, and epigenetic regulators: diet–gene interactions and promoter CpG island hypermethylation in colorectal cancer
por: de Vogel, Stefan, et al.
Publicado: (2010)

Energy balance‐related factors in childhood and adolescence and risk of colorectal cancer expressing different levels of proteins involved in the Warburg‐effect
por: Jenniskens, Josien C. A., et al.
Publicado: (2022)

Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas
por: Voorham, Quirinus JM, et al.
Publicado: (2013)

Histopathological Features in Colonic Biopsies at Diagnosis Predict Long-term Disease Course in Patients with Crohn’s Disease
por: Rezazadeh Ardabili, Ashkan, et al.
Publicado: (2021)

The mTOR Pathway and the Role of Energy Balance Throughout Life in Colorectal Cancer Etiology and Prognosis: Unravelling Mechanisms Through a Multidimensional Molecular Epidemiologic Approach
por: Weijenberg, Matty P., et al.
Publicado: (2013)

Genetic Variants in the Insulin-like Growth Factor Pathway and Colorectal Cancer Risk in the Netherlands Cohort Study
por: Simons, Colinda C. J. M., et al.
Publicado: (2015)

Association between mutational subgroups, Warburg‐subtypes, and survival in patients with colorectal cancer
por: Offermans, Kelly, et al.
Publicado: (2022)

The emerging role of GATA transcription factors in development and disease
por: Lentjes, Marjolein HFM, et al.
Publicado: (2016)

Epidemiological, clinical and endoscopic characteristics of colorectal neuroendocrine neoplasms: a population-based study in the Netherlands
por: Reumkens, Ankie, et al.
Publicado: (2022)

Energy balance-related factors and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status
por: Jenniskens, Josien C. A., et al.
Publicado: (2022)

Energy balance‐related factors in childhood and adolescence and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status
por: Jenniskens, Josien C. A., et al.
Publicado: (2022)

Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine
por: Derks, Sarah, et al.
Publicado: (2013)

Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study
por: Lüchtenborg, Margreet, et al.
Publicado: (2005)

The Emerging Role of Nerves and Glia in Colorectal Cancer
por: Schonkeren, Simone L., et al.
Publicado: (2021)

Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer
por: Szmida, Elzbieta, et al.
Publicado: (2014)

Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer
por: Sahnane, Nora, et al.
Publicado: (2015)

Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers
por: Joosten, S. C., et al.
Publicado: (2021)

Early Life Exposure to Famine and Colorectal Cancer Risk: A Role for Epigenetic Mechanisms
por: Hughes, Laura A. E., et al.
Publicado: (2009)

Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor
por: Salahshor, S, et al.
Publicado: (1999)

Stromal Expression of Hypoxia Regulated Proteins Is an Adverse Prognostic Factor in Colorectal Carcinomas
por: Cleven, Arjen H. G., et al.
Publicado: (2007)

Aberrant Gene Promoter Methylation Associated with Sporadic Multiple Colorectal Cancer
por: Gonzalo, Victoria, et al.
Publicado: (2010)

Multiple Sporadic Colorectal Cancers Display a Unique Methylation Phenotype
por: Gonzalo, Victoria, et al.
Publicado: (2014)

Prognostic and Predictive Value of CpG Island Methylator Phenotype in Patients with Locally Advanced Nonmetastatic Sporadic Colorectal Cancer
por: Wang, Yuwei, et al.
Publicado: (2014)

Lifestyle-Related Factors in the Self-Management of Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer: A Systematic Review
por: Derksen, Tess M. E., et al.
Publicado: (2017)

The Relation of Lifestyle with Inflammation at the Time of Diagnosis in Patients with Colorectal Cancer
por: Gielen, Anke H. C., et al.
Publicado: (2023)

Erratum to “Prognostic and Predictive Value of CpG Island Methylator Phenotype in Patients with Locally Advanced Nonmetastatic Sporadic Colorectal Cancer”
por: Wang, Yuwei, et al.
Publicado: (2014)

Comprehensive Mutation Analysis in Colorectal Flat Adenomas
por: Voorham, Quirinus J. M., et al.
Publicado: (2012)

Clinical Significance and Prognostic Relevance of Microsatellite Instability in Sporadic Colorectal Cancer Patients
por: Copija, Angelika, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m6goahqr8s6tsmn8c27799vfdh